Slaughter and May is advising Johnson Matthey Plc (JM) on the sale of its Medical Device Components business (MDC) to Montagu Private Equity for US$700 million (£550 million) on a cash free, debt free basis.
The MDC business comprises JM’s medical devices manufacturing business which operates in the US, Mexico and Australia. The business produces components for medical device manufacturers globally with a focus on precious metal alloys and nitinol. The sale includes the MDC manufacturing sites in San Diego, Mexicali and Tullamarine.
The transaction, which is subject to regulatory approval, is expected to complete around Q3 2024.
Slaughter and May is working closely with Johnson Matthey’s in-house legal team led by Joanne Holmes and Luke Dovey.
Lily Church / Barrister Secondee, Maria Michael / Trainee, Emma Russell / Trainee, Jason TL Chan / Legal Assistant